Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      Introduction: Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are relatively common and disabling multisystem disorders that share overlapping features, including post-infectious onset and similar clinical manifestations such as brain fog, fatigue, muscle pain, and dysautonomia with orthostatic intolerance. These similarities suggest that Long COVID and ME/CFS may share common pathophysiological mechanisms, though the underlying mechanisms remain poorly understood, partly due to the difficulty in quantifying many of the symptoms.
      Materials and Methods: This retrospective study evaluated Long COVID and pre-COVID ME/CFS patients who completed autonomic testing between 2018 and 2023 at the Brigham and Women's Faulkner Hospital Autonomic Laboratory. The evaluations included autonomic tests (Valsalva maneuver, deep breathing, tilt-table test, and sudomotor function) with capnography and transcranial Doppler monitoring of cerebral blood flow velocity (CBFv) in the middle cerebral artery, neuropathic assessment through skin biopsies for small fiber neuropathy (SFN), invasive cardiopulmonary exercise testing (ICPET), and laboratory analyses covering metabolic, inflammatory, autoimmune, and hormonal profiles.
      Results: A total of 143 Long COVID and 170 ME/CFS patients were analyzed and compared to 73 healthy controls and 290 patients with hypermobile Ehlers-Danlos syndrome (hEDS). Tests revealed extensive similarities between Long COVID and ME/CFS, including reduced orthostatic CBFv (92%/88% in Long COVID/ME/CFS), mild-to-moderate widespread autonomic failure (95%/89%), presence of SFN (67%/53%), postural tachycardia syndrome (POTS) (22%/19%), neurogenic orthostatic hypotension (15%/15%) and preload failure (96%/92%, assessed in 25/66 Long COVID/ME/CFS). Patients with hEDS exhibited more severe peripheral neurodegeneration compared to the other groups. Laboratory tests did not distinguish between the conditions.
      Conclusion: Both Long COVID and ME/CFS demonstrate dysregulation in cerebrovascular blood flow, autonomic reflexes, and small fiber neuropathy, suggesting that these conditions may share a common underlying pathophysiology. However, differing distributions of findings in patients with hEDS raise the question of whether these conditions represent distinct but overlapping syndromes or reflect a shared underlying pathway. Further research is required to clarify the relationship between these conditions and the potential underlying pathophysiological mechanisms.
      (Copyright: © 2026 Novak et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • نبذة مختصرة :
      Dr. Novak is an advisor - independent Contractor for Dysimmune Diseases Foundation. Dr. Novak is a member of the Scientific Advisory Board of Endonovo Therapeutics. Dr. Novak received royalties from Oxford University Press.PN is a current or previous shareholder of Moderna, and Pfizer.
    • References:
      Nat Rev Endocrinol. 2022 Aug;18(8):451-452. (PMID: 35637413)
      Front Aging Neurosci. 2016 Aug 24;8:199. (PMID: 27605912)
      Front Aging Neurosci. 2016 Feb 16;8:22. (PMID: 26909037)
      Cell Rep Med. 2025 Aug 19;6(8):102259. (PMID: 40744021)
      Mayo Clin Proc. 2021 Nov;96(11):2861-2878. (PMID: 34454716)
      J Intern Med. 2011 Oct;270(4):327-38. (PMID: 21777306)
      Front Med (Lausanne). 2023 Jun 02;10:1187163. (PMID: 37342500)
      BMC Cardiovasc Disord. 2020 Apr 22;20(1):190. (PMID: 32321428)
      PLoS Med. 2022 Nov 10;19(11):e1004122. (PMID: 36355754)
      Ther Adv Neurol Disord. 2024 Feb 12;17:17562864241229567. (PMID: 38348267)
      Front Behav Neurosci. 2021 Jan 13;14:601939. (PMID: 33519393)
      Medicine (Baltimore). 2019 Oct;98(43):e17600. (PMID: 31651868)
      Chest. 2022 Jan;161(1):54-63. (PMID: 34389297)
      Medicina (Kaunas). 2021 Dec 24;58(1):. (PMID: 35056336)
      PLoS One. 2017 Oct 20;12(10):e0186885. (PMID: 29053742)
      Dyn Med. 2007 Jan 30;6:2. (PMID: 17263876)
      Stroke. 1998 Sep;29(9):1876-81. (PMID: 9731612)
      Eur J Clin Invest. 2012 Feb;42(2):203-12. (PMID: 21793823)
      Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2426874122. (PMID: 40627388)
      Stroke. 2000 Jul;31(7):1672-8. (PMID: 10884472)
      J Clin Med. 2021 Nov 28;10(23):. (PMID: 34884296)
      Neuroimage Clin. 2024;42:103589. (PMID: 38461701)
      Auton Neurosci. 2022 Sep;241:102997. (PMID: 35679657)
      Lancet Infect Dis. 2022 Apr;22(4):e102-e107. (PMID: 34951953)
      Chest. 2021 Aug;160(2):642-651. (PMID: 33577778)
      Neurol Sci. 2022 Aug;43(8):4821-4828. (PMID: 35347527)
      Nat Commun. 2024 Feb 21;15(1):907. (PMID: 38383456)
      J Appl Physiol (1985). 2014 Apr 1;116(7):844-51. (PMID: 24265279)
      Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):175-180. (PMID: 28186393)
      Clin Ther. 2005 Aug;27(8):1278-94. (PMID: 16199253)
      JAMA. 2023 Jun 13;329(22):1934-1946. (PMID: 37278994)
      Crit Care Med. 2006 Apr;34(4):1243-6. (PMID: 16484893)
      Pediatr Res. 2000 Aug;48(2):218-26. (PMID: 10926298)
      Stat Med. 1992 Oct-Nov;11(14-15):1825-39. (PMID: 1480876)
      Front Psychol. 2016 Sep 30;7:1466. (PMID: 27746750)
      Clin Auton Res. 2021 Jun;31(3):385-394. (PMID: 33860871)
      Psychiatry Clin Neurosci. 2003 Aug;57(4):361-8. (PMID: 12839515)
      Nat Med. 2019 Dec;25(12):1822-1832. (PMID: 31806905)
      Sci Adv. 2015 Feb;1(1):. (PMID: 26079000)
      Neurology. 2011 Jun 7;76(23):2010-6. (PMID: 21646629)
      Medicina (Kaunas). 2021 Apr 26;57(5):. (PMID: 33925784)
      Circulation. 2013 Mar 12;127(10):1157-64. (PMID: 23479667)
      Brain. 2008 Jul;131(Pt 7):1912-25. (PMID: 18524793)
      Curr Neurol Neurosci Rep. 2019 Nov 26;19(12):103. (PMID: 31773305)
      Clin Auton Res. 2019 Feb;29(1):17-29. (PMID: 28951985)
      Pain Pract. 2017 Feb;17(2):166-175. (PMID: 26989894)
      Am J Med Genet. 1998 Apr 28;77(1):31-7. (PMID: 9557891)
      Clin Auton Res. 2011 Apr;21(2):69-72. (PMID: 21431947)
      Neurosci Lett. 2012 Sep 13;525(2):117-22. (PMID: 22842394)
      Eur J Pain. 2016 Sep;20(8):1319-25. (PMID: 26919608)
      Neurol Sci. 2022 Dec;43(12):6627-6638. (PMID: 36169757)
      Diagnostics (Basel). 2024 Mar 28;14(7):. (PMID: 38611624)
      Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H664-73. (PMID: 19502561)
      J Magn Reson Imaging. 2023 Aug;58(2):593-602. (PMID: 36472248)
      Heart Rhythm. 2022 Nov;19(11):1880-1889. (PMID: 35853576)
      Sci Rep. 2023 Apr 10;13(1):5808. (PMID: 37037833)
      Pharmacol Rev. 2004 Sep;56(3):331-49. (PMID: 15317907)
      Pain. 2011 Mar;152(3 Suppl):S2-S15. (PMID: 20961685)
      Mayo Clin Proc. 2023 Oct;98(10):1544-1551. (PMID: 37793728)
      J Clin Neurophysiol. 2021 Jul 1;38(4):274-278. (PMID: 34009850)
      Neurology. 2011 Mar 22;76(12):1099-105. (PMID: 21422460)
      Neurology. 2013 Mar 12;80(11 Suppl 3):S49-53. (PMID: 23479545)
      Am J Physiol Heart Circ Physiol. 2014 Oct 1;307(7):H1005-12. (PMID: 25063795)
      Ann Neurol. 2022 Mar;91(3):367-379. (PMID: 34952975)
      Neurol Clin Pract. 2025 Jun;15(3):e200463. (PMID: 40190589)
      Clin Auton Res. 2018 Jun;28(3):273-288. (PMID: 29705971)
      Dev Dyn. 2021 Mar;250(3):318-344. (PMID: 32629534)
      Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26. (PMID: 28306229)
      Commun Med (Lond). 2025 Apr 11;5(1):109. (PMID: 40210986)
      Neurol Sci. 2024 Dec;45(12):5771-5778. (PMID: 38980457)
      Oncotarget. 2017 Jun 29;8(43):75381-75388. (PMID: 29088873)
      Muscle Nerve. 2020 Apr;61(4):512-515. (PMID: 31650561)
      Curr Neurol Neurosci Rep. 2023 Dec;23(12):881-892. (PMID: 37947962)
    • الموضوع:
      Date Created: 20260123 Date Completed: 20260123 Latest Revision: 20260126
    • الموضوع:
      20260130
    • الرقم المعرف:
      PMC12829881
    • الرقم المعرف:
      10.1371/journal.pone.0341278
    • الرقم المعرف:
      41576003